Fundamentals of Obesity Treatment Virtual Course

The Fundamentals of Obesity Treatment Course is now virtual! This is a 2-day interactive virtual course offering introductory education about the evidence-based approaches for evaluating, diagnosing, and treating obesity in a clinical setting. The content is appropriate for physicians, nurse practitioners, physician assistants, clinicians-in-training, and other healthcare providers who treat patients with the disease of obesity.

On the first day, attend virtual lectures to learn about the basic concepts that define obesity as a disease, the pathophysiology of obesity, and how to evaluate patients for obesity and related diseases using ethical, non-stigmatizing communication. Then review strategies for treating obesity using four treatment pillars: nutrition, physical activity, behavior, and pharmacotherapy. On the second day, work in virtual breakout groups on patient cases to develop comprehensive treatment plans using interventions in all four treatment pillars. Gain tools to begin developing effective treatment plans for patients affected by obesity in your practice.

Register Now

2021 Course Dates

Click on the boxes below to view more details about that course.

February 26-27, 2021

Register Now

This course is worth up to 9.5 CME/CE credits.

OMA Members: $190
Non-members: $225
Clinician-in-training: $50

This course is offered online. Approximately one week before the course begins, you will receive an email with instructions for accessing the online course and materials.


Friday, February 26 – 1:25 – 7:00 PM EDT
Saturday, February 27 – 10:00 AM – 4:00 PM EDT

Why Attend?

Fundamentals of Obesity Treatment

As a result of attending this course, you will be able to:

  • Recognize obesity as a disease with diverse etiologies.
  • Explain the basic physiologic processes involved in the disease of obesity.
  • Distinguish the various methods currently utilized to screen and diagnose overweight and obesity.
  • Perform a history and physical exam, and order testing specifically directed to evaluate and assess the disease of obesity and its potential underlying causes.
  • Recognize the manifestations of obesity-related diseases in a clinical setting.
  • Communicate with patients about their weight and any related conditions comfortably and compassionately in a non-threatening environment.
  • Recognize the importance of using a long-term approach to obesity treatment.
  • Develop nutritional treatment interventions tailored to the unique needs of patients affected by obesity.
  • Prescribe an individualized physical activity plan for patients affected by obesity.
  • Develop behavioral modification strategies unique to each patient’s needs.
  • Use anti-obesity medications appropriately as part of an overall treatment plan.
  • Implement a comprehensive individualized obesity treatment plan utilizing the pillars of obesity treatment (nutrition, physical activity, behavioral interventions, and pharmacotherapy) through interactive case studies.

Who Should Attend?

  • Physicians
  • Nurse practitioners
  • Physician assistants
  • Nurses
  • Pharmacists
  • Psychologists
  • Dietitians and nutritionists
  • Medical students, residents, and fellows

2021 Virtual Course Schedule

Friday Schedule

1:25–1:30 PM EDT – Welcome

1:30–2:30 PM EDT – Understanding the Chronic Disease of Obesity (1.0 CME/CE)

2:30–3:30 PM EDT – Nutrition (1 CME/CE)

3:30–3:45 PM EDT – Break

3:45–4:30 PM EDT – Physical Activity (.75 CME/CE)

4:30-5:15 PM EDT– Behavior (.75 CME/CE)

5:15–5:30 PM EDT – Break

5:30–6:45 PM EDT – Medication (1.25 CME/CE)

6:45–7:00 PM EDT – Question and Answer Session (.25 CME/CE)

Saturday Schedule

10:00–10:15 AM EDT – Q&A and introduction to casework (.25 CME/CE)

10:15–11:15 AM EDT – Case Discussion 1 (1 CME/CE)

11:15–11:30 AM EDT – Break

11:30 AM–12:30 PM EDT – Case Discussion 2 (1 CME/CE)

12:30–1:30 PM EDT – Case Discussion 3 (1 CME/CE)

1:30–2:00 PM EDT – Break

2:00–3:00 PM EDT – Case Discussion 4 (1 CME/CE)

3:00–3:15 PM EDT – Question and Answer Session and Conclusion (.25 CME/CE)


  • The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • The Obesity Medicine Association designates this live activity for a maximum of 9.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • The Obesity Medicine Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The Obesity Medicine Association designates this program for a maximum of 9.50 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in the activity.
  • This Live activity, Fundamentals of Obesity Treatment, from 02/28/2020 – 11/14/2020, has been reviewed and is acceptable for up to 9.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • This activity is approved for 9.5 contact hour(s) of continuing education (which includes 2.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20024120. This activity was planned in accordance with AANP Accreditation Standards and Policies.
  • This activity is approved by the Commission on Dietetic Registration (CDR) for 9.5 CPEUs.

Education Support

This activity is supported by independent education grants from Novo Nordisk, Inc. and Rhythm Pharmaceuticals.